Efficacy and safety of aflibercept therapy for diabetic macular edema: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of aflibercept therapy for diabetic macular edema: A systematic review and meta-analysis

Published:2022 Issue:2 Volume:34 Page:133
ISSN:2452-2325
Container-title:Journal of Current Ophthalmology
language:en
Short-container-title:J Curr Ophthalmol

Author:

Santhakumaran Sangeetha,Salimi Ali,Brunetti VanessaC,Galic John

Publisher

Medknow

Subject

Ophthalmology

Reference50 articles.

1. Current epidemiology of diabetic retinopathy and diabetic macular edema;Ding;Curr Diab Rep,2012

2. Treatment of diabetic macular edema;Kim;Curr Diab Rep,2019

3. Health Canada. Avastin. In: Canada H, editor. Drug Product Database. Ottawa, Ontario, Canada: Health Canada; 2005.

4. Lucentis. Government of Canada; 2007. Available from: https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78217. [Last accessed on 2021 Jul 10].

5. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema;Diabetic;N Engl J Med,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective Effect of Topiramate against Diabetic Retinopathy and Computational Approach Recognizing the Role of NLRP3/IL-1β/TNF-α Signaling;Biomedicines;2023-12-01

2. Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study;Ophthalmology and Therapy;2023-11-04

3. Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study;Ophthalmology and Therapy;2023-11-04

4. Comparison between intravitreal brolucizumab and aflibercept in the treatment-naive central involved diabetic macular edema: One-year real-life case series;European Journal of Ophthalmology;2023-10-10

5. Aflibercept for Diabetic Macular Edema in Real-Life Practice in GREece: Three-Year Outcomes of the ADMIRE Study;Seminars in Ophthalmology;2023-08-04